Historic Accumulated Expenses for Nuvation Bio (NUVB) over the last 4 years, with Jun 2025 value amounting to $24.0 million.
- Nuvation Bio's Accumulated Expenses rose 20.15% to $24.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $24.0 million, marking a year-over-year increase of 20.15%. This contributed to the annual value of $32.8 million for FY2024, which is 235.27% up from last year.
- Latest data reveals that Nuvation Bio reported Accumulated Expenses of $24.0 million as of Q2 2025, which was up 0.44% from $23.9 million recorded in Q1 2025.
- Over the past 5 years, Nuvation Bio's Accumulated Expenses peaked at $24.0 million during Q2 2025, and registered a low of $4.0 million during Q1 2021.
- In the last 3 years, Nuvation Bio's Accumulated Expenses had a median value of $15.9 million in 2023 and averaged $16.6 million.
- Data for Nuvation Bio's Accumulated Expenses shows a peak YoY soared of 8,359.50% (in 2021) over the last 5 years.
- Over the past 5 years, Nuvation Bio's Accumulated Expenses (Quarterly) stood at $8.1 million in 2021, then increased by 21.74% to $9.9 million in 2022, then rose by 19.55% to $11.9 million in 2023, then soared by 98.28% to $23.5 million in 2024, then rose by 20.15% to $24.0 million in 2025.
- Its last three reported values are $24.0 million in Q2 2025, $23.9 million for Q1 2025, and $23.5 million during Q3 2024.
